PPARGC1A and Disorder of lipid metabolism: Dehydroepiandrosterone can impede high-fat-induced hepatic glucose and lipid metabolic disorder and IR by activating the AMPK-PGC-1α-NRF-1 pathway [20], yet whether PGC-1α is involved in glucose and lipid metabolism in PCOS patients remains unclear.